Indication
Anogenital Cancers
1 clinical trial
12 products
Product
TSC-200-A0201Clinical trial
A Phase 1 Basket Study Evaluating the Safety and Feasibility of T-Plex, Autologous Customized T Cell Receptor-Engineered T Cells Targeting Multiple Peptide/HLA Antigens in Participants With Antigen-positive Locally Advanced (Unresectable) or Metastatic Solid TumorsStatus: Recruiting, Estimated PCD: 2026-12-30
Product
TSC-203-A0201Product
TSC-204-A0101Product
TSC-201-B0702Product
TSC-204-A0201Product
TSC-204-C0702Product
TSC-204